AUPM456894A0 - Treatment for gastric disorders - Google Patents
Treatment for gastric disordersInfo
- Publication number
- AUPM456894A0 AUPM456894A0 AUPM4568A AUPM456894A AUPM456894A0 AU PM456894 A0 AUPM456894 A0 AU PM456894A0 AU PM4568 A AUPM4568 A AU PM4568A AU PM456894 A AUPM456894 A AU PM456894A AU PM456894 A0 AUPM456894 A0 AU PM456894A0
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- gastric disorders
- gastric
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM4568A AUPM456894A0 (en) | 1994-03-18 | 1994-03-18 | Treatment for gastric disorders |
PCT/AU1995/000146 WO1995025513A1 (en) | 1994-03-18 | 1995-03-17 | Zinc compound and cyclodextrine for treatment of gastric disorders |
AU20611/95A AU2061195A (en) | 1994-03-18 | 1995-03-17 | Zinc compound and cyclodextrine for treatment of gastric disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM4568A AUPM456894A0 (en) | 1994-03-18 | 1994-03-18 | Treatment for gastric disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPM456894A0 true AUPM456894A0 (en) | 1994-04-14 |
Family
ID=3779183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPM4568A Abandoned AUPM456894A0 (en) | 1994-03-18 | 1994-03-18 | Treatment for gastric disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPM456894A0 (en) |
WO (1) | WO1995025513A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69637442T2 (en) * | 1995-12-22 | 2008-05-21 | Nagase Chemtex Corp. | ACTIVE AGAINST HELICOBACTER PYLORI |
GB9621273D0 (en) | 1996-10-11 | 1996-11-27 | Cortecs Ltd | Therapeutic method |
EP1735326A4 (en) * | 2004-01-29 | 2011-04-20 | Pinnacle Pharmaceuticals | Beta-cyclodextrin derivatives and their use against anthrax lethal toxin |
MX2007000201A (en) | 2004-06-30 | 2007-06-15 | Nutrition Sciences Nv | Medium chain fatty acids applicable as anti-microbial agents. |
DK1976532T3 (en) | 2006-01-27 | 2016-02-01 | Univ Yale | FAST-ACTING INHIBITOR of gastric acid secretion |
US8512761B2 (en) | 2006-01-27 | 2013-08-20 | Yale University | Fast acting inhibitor of gastric acid secretion |
US9420795B2 (en) | 2011-07-27 | 2016-08-23 | Matterworks One Limited | Glycolate formulation for preserving wood and like materials |
CN106511351B (en) * | 2016-12-27 | 2020-04-03 | 吉林省博大伟业制药有限公司 | Application of polaprezinc in preparation of anti-helicobacter pylori medicines |
IT202000025066A1 (en) * | 2020-10-22 | 2022-04-22 | Difass Int S R L | COMPOSITION INCLUDING MACROCYSTIS PYRIFERA, CARNOSINE AND ZINC FOR THE TREATMENT OF HELICOBACTER PYLORI INFECTION |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5095035A (en) * | 1981-07-31 | 1992-03-10 | Eby Iii George A | Flavor stable zinc acetate compositions for oral absorption |
JPH072629B2 (en) * | 1987-07-01 | 1995-01-18 | 花王株式会社 | Water-soluble antibacterial agent and cosmetics containing the same |
GB9004328D0 (en) * | 1990-02-27 | 1990-04-25 | Glaxo Group Ltd | Chemical compounds |
JPH06172189A (en) * | 1992-08-17 | 1994-06-21 | Bristol Myers Squibb Co | Composite agent for protection of stomach and intestine |
IT1263831B (en) * | 1993-01-29 | 1996-09-04 | Paolo Chiesi | MULTI-COMPONENT INCLUSION COMPLEXES WITH HIGH SOLUBILITY CONSTITUTED BY A BASIC-TYPE DRUG, AN ACID AND A CYCLODEXTRINE |
-
1994
- 1994-03-18 AU AUPM4568A patent/AUPM456894A0/en not_active Abandoned
-
1995
- 1995-03-17 WO PCT/AU1995/000146 patent/WO1995025513A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1995025513A1 (en) | 1995-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
AU3153295A (en) | Methods for treating addictive disorders | |
AU2805195A (en) | Therapeutic compounds | |
AU1139095A (en) | Combination treatment for osteoporosis | |
AU3341395A (en) | Vibration-compensating apparatus | |
AU7772794A (en) | Treatment of obesity | |
AU2474195A (en) | Catheter apparatus | |
AU1542895A (en) | Surface treatment | |
AU3095595A (en) | Dimension-measuring apparatus | |
AU2424895A (en) | Substituted spirodienes for the treatment of inflammation | |
AU2555397A (en) | Macrophage stimulating protein for the treatment of gastrointestinal disorders | |
AU2557895A (en) | Composition for treating gastrointestinal disorders | |
AUPM456894A0 (en) | Treatment for gastric disorders | |
AU8179494A (en) | Tab for can | |
AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
AU2705195A (en) | Incontinence treatment | |
AU2547895A (en) | Therapeutic phenoxyalkylheterocycles | |
AU7018794A (en) | Methods for treating pathologies | |
AU3860995A (en) | Adjusting means | |
AU6581294A (en) | Ethanolamine derivatives useful for the treatment of gastrointestinal disorders | |
EP0724842A3 (en) | Preparation for the treatment of obesity | |
AU2291595A (en) | Turning apparatus | |
AU3874795A (en) | Oral treatment | |
AU2671895A (en) | Bisquinolines for the treatment of malaria | |
AU2245695A (en) | Composition for treating neurological disorders |